Detalhe da pesquisa
1.
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Prostate
; 82(5): 584-597, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084050
2.
Clinical assays for assessment of homologous recombination DNA repair deficiency.
Gynecol Oncol
; 159(3): 887-898, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012552
3.
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
Gynecol Oncol
; 159(1): 72-78, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771276
4.
Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer.
Int J Mol Sci
; 21(22)2020 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217970
5.
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
Genet Med
; 19(7): 787-795, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28125075
6.
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.
JCO Precis Oncol
; 8: e2300635, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635934
7.
Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
JCO Precis Oncol
; 7: e2300290, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061009
8.
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.
Cancer Cell
; 3(5): 459-69, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12781364
9.
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma.
Gynecol Oncol Rep
; 40: 100974, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35434236
10.
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer.
Clin Cancer Res
; 28(15): 3356-3366, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443043
11.
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype.
J Clin Invest
; 132(16)2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708912
12.
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
Genome Med
; 13(1): 89, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016182
13.
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer.
Nat Commun
; 12(1): 5574, 2021 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552099
14.
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.
JCO Precis Oncol
; 4: 1084-1097, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050773
15.
A single-cell landscape of high-grade serous ovarian cancer.
Nat Med
; 26(8): 1271-1279, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572264
16.
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
Nat Med
; 26(8): 1307, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587393
17.
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
Nat Med
; 26(5): 792-802, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32405060
18.
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer.
Mol Cancer Res
; 17(11): 2281-2293, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462500
19.
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.
Cell Rep
; 25(11): 2972-2980.e5, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30540933
20.
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
N Engl J Med
; 348(13): 1201-14, 2003 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-12660384